Newgenivf Group Limited Stock Performance

NIVF Stock   1.07  0.01  0.94%   
The company secures a Beta (Market Risk) of 0.29, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NewGenIvf Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding NewGenIvf Group is expected to be smaller as well. At this point, NewGenIvf Group has a negative expected return of -2.57%. Please make sure to verify NewGenIvf Group's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if NewGenIvf Group performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NewGenIvf Group Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Last Split Factor
1:20
Last Split Date
2025-02-11
1
NewGen Engages OSL to Execute Strategic Investment in Digital Assets
12/19/2024
2
NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology
01/21/2025
3
NewGenIvf to execute reverse stock split
01/31/2025
4
NewGen Issues Clarification on Press Release Titled NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director dated Febr...
02/20/2025
5
NewGenIvf Group receives approval for continued Nasdaq listing shares rise - MSN
02/21/2025
6
NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan
03/03/2025
7
NIVF Stock Plummets to 52-Week Low at 1.02 Amid Market Turbulence - Investing.com
03/11/2025
Begin Period Cash Flow54.7 K
  

NewGenIvf Group Relative Risk vs. Return Landscape

If you would invest  847.00  in NewGenIvf Group Limited on December 17, 2024 and sell it today you would lose (740.00) from holding NewGenIvf Group Limited or give up 87.37% of portfolio value over 90 days. NewGenIvf Group Limited is currently does not generate positive expected returns and assumes 12.6763% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NewGenIvf, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days NewGenIvf Group is expected to under-perform the market. In addition to that, the company is 14.07 times more volatile than its market benchmark. It trades about -0.2 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.08 per unit of volatility.

NewGenIvf Group Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for NewGenIvf Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NewGenIvf Group Limited, and traders can use it to determine the average amount a NewGenIvf Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.2024

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNIVF

Estimated Market Risk

 12.68
  actual daily
96
96% of assets are less volatile

Expected Return

 -2.57
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.2
  actual daily
0
Most of other assets perform better
Based on monthly moving average NewGenIvf Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NewGenIvf Group by adding NewGenIvf Group to a well-diversified portfolio.

NewGenIvf Group Fundamentals Growth

NewGenIvf Stock prices reflect investors' perceptions of the future prospects and financial health of NewGenIvf Group, and NewGenIvf Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NewGenIvf Stock performance.

About NewGenIvf Group Performance

By analyzing NewGenIvf Group's fundamental ratios, stakeholders can gain valuable insights into NewGenIvf Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NewGenIvf Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NewGenIvf Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 12.01  12.61 
Return On Tangible Assets(0.48)(0.46)
Return On Capital Employed 0.07  0.08 
Return On Assets(0.48)(0.46)
Return On Equity(0.05)(0.05)

Things to note about NewGenIvf Group performance evaluation

Checking the ongoing alerts about NewGenIvf Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NewGenIvf Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
NewGenIvf Group generated a negative expected return over the last 90 days
NewGenIvf Group has high historical volatility and very poor performance
NewGenIvf Group has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 5.14 M. Net Loss for the year was (690.85 K) with profit before overhead, payroll, taxes, and interest of 1.48 M.
NewGenIvf Group generates negative cash flow from operations
Latest headline from news.google.com: NIVF Stock Plummets to 52-Week Low at 1.02 Amid Market Turbulence - Investing.com
Evaluating NewGenIvf Group's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate NewGenIvf Group's stock performance include:
  • Analyzing NewGenIvf Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NewGenIvf Group's stock is overvalued or undervalued compared to its peers.
  • Examining NewGenIvf Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating NewGenIvf Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NewGenIvf Group's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of NewGenIvf Group's stock. These opinions can provide insight into NewGenIvf Group's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating NewGenIvf Group's stock performance is not an exact science, and many factors can impact NewGenIvf Group's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for NewGenIvf Stock analysis

When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges